News and Events

Treatment-related adverse events with nivolumab

4 February 2017

Treatment-related adverse events with nivolumab monotherapy are primarily low grade and not influenced by prior treatment with ipilimumab, according to the results of a large, comprehensive analysis.  Researchers indicate, however, that there appears to be an interaction between what leads to tumor regression and toxicities, i.e., patients treated with nivolumab who experience immune-related adverse events have a higher overall response rate.

Role of oncology nurses in protecting cancer patients

3 February 2017

Oncology nurses can play an important role in protecting their patients from future skin cancer morbidity and mortality, according to a review of research and evidence-based resources on skin cancer prevention.

Skin cancer prevention can be life-saving and cost-saving

2 February 2017

“A comprehensive skin cancer prevention program can be both life-saving and cost-saving,” according to authors of a recent Australia study.  Based upon their analysis,“a potential return of $3.20 can be achieved for every dollar invested”.

Economic and mortality benefits of under 18 sunbed bans

24 January 2017

Reducing indoor tanning has the potential to reduce melanoma incidence, mortality, and treatment costs, according to authors of a recent US study.  In the US such bans could prevent 6735 melanoma deaths and save $342.9 million. 

Consumer acceptance of mobile teledermoscopy

24 January 2017

Consumer acceptance of mobile teledermoscopy appears to be favourable, according to authors of this study.  They caution, however, that “many practical aspects still need to be resolved before mobile teledermoscopy is ready for widespread consumer use”. 

Increasing skin self-examination after melanoma diagnosis

23 January 2017

A tablet-based intervention may help to reinforce and sustain skin self-examination, thereby facilitating earlier detection of recurrence following treatment for melanoma, according to authors of a recent study.

Men over 70 years possible best target for early detection education

17 January 2017

Among patients with melanomas that were self-detected, those found by women had better prognoses than those that were self-detected by men, especially for patients >70 years of age, according to authors of this study. They conclude that this group “might therefore be a logical target for melanoma detection education”.